The number of bridge loans pricing below 100bp is increasing.
Reckitt Benckiser, the UK health and hygiene firm, recently closed a $20bn acquisition facility that some 20 banks funded. The $8bn one year bridge loan offered lenders margins of less than 30bp.This followed Bayer’s $57bn loan, which went ...
Please take a trial or subscribe to access this content.
Contact Mark Goodes to discuss your access: email@example.com